Innohep

(redirected from tinzaparin sodium)
Also found in: Wikipedia.

Innohep®

See Tinzaparin.

Innohep

A brand name for TINZAPARIN.
References in periodicals archive ?
Contract notice: conclusion of a non-exclusive discount agreement pursuant to 130a (8) sgb v on the active substance tinzaparin sodium, atc b01ab10, for the period 1.2.2019 - 31.1.2021
irrespective of this, it automatically ends with the entry into force of the tinzaparin sodium exclusive contract, atc b01ab10, as a result of a formal award procedure in accordance with the regulations of part 4 of the gwb with one or more contractual partners.
Enoxaparin is the most commonly used agent in the existing trials.67 Tinzaparin sodium is also a LMWH and its biochemical and pharmacokinetic differences from enoxaparin may have clinically important effects.8 The data about the administration of tinzaparin during pregnancy is limited.
Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss.
Further, of these LMWHs, the experience with tinzaparin sodium (Innohep, Leo Pharmaceutical Corp.) is limited [12, 15, 24].
Blumgart that a resident ordered Tinzaparin Sodium, 4,500 units by injection subcutaneously daily, but it was discontinued by another on November 30, 2005, because of concern about employing anticoagulants in patients at that stage with a hepatic resection.
Contract awarded for Low molecular weight heparin anti-xa activity of 2,500 to 4,000 iu, solution for injection: certroparin sodium or, dalteparin sodium or, enoxaparin sodium, or calcium nadroparin or, tinzaparin sodium, bemiparin.